₹1,178.3
▼ -12.02 -1.01%
As of 06 Nov 2026 · delayed
NSE Listed
Sudeep Pharma Limited (SUDEEPPHRM)
Volume: 2,48,246Avg Vol 1W: 2,02,101.2Avg Vol 1M: 3,16,697.652W Range:₹524.05₹1,378
Key Ratios
Checked 8h agoMarket Cap₹13,309 Cr
Current Price₹1,178.3
Previous Close₹1,190.32
High / Low (52w)₹1,378 / ₹524.05
Volume2,48,246
Avg Vol (1W)2,02,101.2
Avg Vol (1M)3,16,697.6
Stock P/E70.68
Book Value₹84.76
Dividend Yield0%
ROE19.67%
ROA14.2%
Revenue (TTM)₹671 Cr
Revenue Growth9.3%
Profit Margin26.54%
Total Debt₹40 Cr
Shares Outstanding11 Cr
Face Value₹1
EPS (TTM)₹16.67
P/B13.9
Debt / Equity0.21
50 DMA₹1,137.04
200 DMA₹844.67
Day change-1.01%
Price Chart
₹1,178.3▲ 52.21% · 1Y
2025-11-282026-11-06
20-day avg volume: 3.2L shares
Pros
- Healthy return on equity of 19.7%.
- Company is almost debt-free.
Cons
- Revenue fell 42% YoY.
- Stock trades at a high P/E of 71.
Quarterly Results
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹116 Cr | ₹158 Cr | ₹125 Cr | ₹163 Cr | ₹172 Cr | ₹182 Cr | ₹158 Cr | ₹197 Cr |
| EBITDA | ₹39 Cr | ₹60 Cr | ₹46 Cr | ₹62 Cr | ₹63 Cr | ₹65 Cr | ₹56 Cr | ₹74 Cr |
| Net Profit | ₹29 Cr | ₹44 Cr | ₹31 Cr | ₹46 Cr | ₹47 Cr | ₹49 Cr | ₹41 Cr | ₹51 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Mar 2026 | Jun 2026 | Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹105 Cr | ₹80 Cr | ₹88 Cr | ₹90 Cr | ₹671 Cr | ₹80 Cr | ₹106 Cr | ₹137 Cr |
| EBITDA | ₹47 Cr | ₹35 Cr | ₹42 Cr | ₹37 Cr | ₹236 Cr | ₹37 Cr | ₹47 Cr | ₹59 Cr |
| Net Profit | ₹33 Cr | ₹25 Cr | ₹30 Cr | ₹27 Cr | ₹173 Cr | ₹26 Cr | ₹34 Cr | ₹42 Cr |
| EPS | — | — | — | — | 15.5 | — | — | — |
Balance Sheet
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Total Assets | ₹131 Cr | ₹213 Cr | ₹344 Cr | ₹420 Cr | ₹514 Cr | ₹717 Cr | ₹1,175 Cr |
| Total Liabilities | ₹50 Cr | ₹99 Cr | ₹180 Cr | ₹197 Cr | ₹158 Cr | ₹224 Cr | ₹277 Cr |
| Equity | ₹81 Cr | ₹114 Cr | ₹163 Cr | ₹223 Cr | ₹356 Cr | ₹493 Cr | ₹898 Cr |
| Total Debt | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | ₹16 Cr | ₹46 Cr | ₹15 Cr | ₹71 Cr | ₹110 Cr | ₹89 Cr | ₹125 Cr |
| Investing | ₹-22 Cr | ₹-40 Cr | ₹-38 Cr | ₹-50 Cr | ₹-49 Cr | ₹-79 Cr | ₹-331 Cr |
| Financing | ₹12 Cr | ₹13 Cr | ₹51 Cr | ₹-10 Cr | ₹-13 Cr | ₹53 Cr | ₹247 Cr |
| Free Cash Flow | ₹16 Cr | ₹46 Cr | ₹15 Cr | ₹71 Cr | ₹110 Cr | ₹89 Cr | ₹125 Cr |
Shareholding
Promoter 76.15% Institutions 16.98% Public 6.87%
Efficiency & Working Capital
ROCE21.9%
Interest Coverage27.8
Dividend Payout—
Debtor Days129 d
Inventory Days123 d
Payable Days39 d
Cash Conversion Cycle213 d
Working Capital Days252 d
Shareholding Details
As of 2026-09-30
Promoter76.2%
FII2.9%
DII14.1%
Institutions17%
Public6.9%
Promoter Pledge0%
No. of Shareholders40,465
Shareholding Pattern
Quarterly — figures in %. Latest 7 quarters.
| Period | Jun 2025 | Nov 2025 | Nov 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 |
|---|---|---|---|---|---|---|---|
| Promoters | 91.1% | 76.2% | 76.2% | 76.2% | 76.2% | 76.2% | 76.2% |
| FIIs | 0% | 0.9% | 1.5% | 1.7% | 1.6% | 1.8% | 2.9% |
| DIIs | 0% | 14.8% | 14.8% | 17.6% | 18.1% | 15.6% | 14.1% |
| Public | 8.9% | 8.2% | 7.5% | 4.6% | 4.2% | 6.4% | 6.9% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 16 | 2,17,982 | 2,17,982 | 43,599 | 36,503 | 35,695 | 40,465 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Riva Resources Private Limited | Shareholding of Promoter and Promoter Group | 40.4% | 4.56 Cr |
| Bhayani Sujit Jaysukh | Shareholding of Promoter and Promoter Group | 21.2% | 2.39 Cr |
| Sujeet Jaysukh Bhayani Huf | Shareholding of Promoter and Promoter Group | 5.7% | 64,60,747 |
| Avani Sujeet Bhayani | Shareholding of Promoter and Promoter Group | 4.5% | 50,53,140 |
| Shanil Sujit Bhayani | Shareholding of Promoter and Promoter Group | 4.5% | 50,25,000 |
| Sbi Healthcare Opportunities Fund | Public Shareholding | 2.9% | 32,15,590 |
| Nuvama Crossover Opportunities Fund - Series Iii B | Public Shareholding | 2.1% | 24,16,427 |
| Axis Mutual Fund Trustee Limited A/c Axis Mutual Fund A/c Axis Small Cap Fund | Public Shareholding | 1.8% | 20,41,301 |
| Mukul Mahavir Agrawal | Public Shareholding | 1.3% | 15,00,117 |
| Nuvama Crossover Opportunities Fund - Series Iii | Public Shareholding | 1.1% | 12,51,237 |
| Nuvama Crossover Opportunities Fund - Series Iii A | Public Shareholding | 1.1% | 12,18,850 |
| Jaysukh Jayantilal Bhayani | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Dipen Jaysukh Bhayani | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Urvir Jaysukh Bhayani | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Rhea Sujit Bhayani | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Anjana Rajendrabhai Patel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Rajendra Chunilal Patel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Vidhi Shanil Bhayani | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Inaraa Shanil Bhayani | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Alka Pravinchandra Kotak | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Pravinchandra Talakshibhai Kotak | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Harsh Pravinbhai Kotak | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Dipen Jaysukh Bhayani Huf | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Urvir Jaysukh Bhayani Huf | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Pravinbhai Talkshibhai Thakkar Huf | Shareholding of Promoter and Promoter Group | 0% | 0 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Sujit J Bhayani | Chairman / Executive Director / Managing Director | 2026 |
| Shanil Sujit Bhayani | E D & Wholetime Director | 2026 |
| Ajay Shrirang Kandelkar | E D & Wholetime Director | 2026 |
| Milin Mehta | Non-Exec & Non-Independent Dir | 2026 |
| S. Raghunandan | Independent Non Exe. Director | 2026 |
| Samaresh Panda | Independent Non Exe. Director | 2026 |
| Reshma Patel | Independent Non Exe. Director | 2026 |
| Sujit Gulati | Independent Non Exe. Director | 2026 |
| Dimple Ashwinbhai Mehta | Company Sec. & Compli. Officer | 2026 |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹149 Cr | 44% |
| USA | ₹27 Cr | 8% |
| Others | ₹162 Cr | 48% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹1 | 12 | 11 | 11 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-08-04 | Board Meetings | — |
| forthcoming | 2026-07-23 | Dividend (1.5/- per share) | Final |
| dividend | 2026-07-23 | ₹1.5 (150%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 676 | 0 | 0 | 3 | 39 | 718 |
| 2026 | 308 | 0 | 0 | 0 | 0 | 308 |
| 2026 | 16 | 0 | 0 | 3 | 38 | 57 |
Company Information
🌐 www.sudeeppharma.com ↗
📍 129/1/A GIDC Estate Nandesari, Vadodara, Gujarat, 391340
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Suba Hotels LimitedSubex Ltd.Subros LimitedSudarshan Colorants India Ltd.Sudarshan Chemical Industries Ltd.Sudarshan Pharma Industries Ltd.Sukhjit Starch & Chemicals Ltd.Sula Vineyards LimitedSumax Engineering LimitedSumedha Fiscal Services LimitedSumeet Industries Ltd.Sumeet Industries Ltd.All “S” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search